166 related articles for article (PubMed ID: 18580476)
1. Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker.
Kosmoliaptsis V; Bradley JA; Sharples LD; Chaudhry A; Key T; Goodman RS; Taylor CJ
Transplantation; 2008 Jun; 85(12):1817-25. PubMed ID: 18580476
[TBL] [Abstract][Full Text] [Related]
2. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
[TBL] [Abstract][Full Text] [Related]
3. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
[TBL] [Abstract][Full Text] [Related]
4. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
[TBL] [Abstract][Full Text] [Related]
5. Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.
Kosmoliaptsis V; Sharples LD; Chaudhry AN; Halsall DJ; Bradley JA; Taylor CJ
Transplantation; 2011 Jan; 91(2):183-90. PubMed ID: 21079553
[TBL] [Abstract][Full Text] [Related]
6. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity.
Duquesnoy RJ
Int J Immunogenet; 2012 Feb; 39(1):1-9. PubMed ID: 21981757
[TBL] [Abstract][Full Text] [Related]
7. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.
Duquesnoy RJ; Marrari M
Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979
[TBL] [Abstract][Full Text] [Related]
8. Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.
Kosmoliaptsis V; Chaudhry AN; Sharples LD; Halsall DJ; Dafforn TR; Bradley JA; Taylor CJ
Transplantation; 2009 Sep; 88(6):791-8. PubMed ID: 19920778
[TBL] [Abstract][Full Text] [Related]
9. Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies.
Duquesnoy RJ; Marrari M; Mulder A; Claas FH; Mostecki J; Balazs I
Hum Immunol; 2012 Mar; 73(3):267-77. PubMed ID: 22227099
[TBL] [Abstract][Full Text] [Related]
10. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
Duquesnoy RJ; Howe J; Takemoto S
Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
[TBL] [Abstract][Full Text] [Related]
11. Antibody-reactive class I epitopes defined by pairs of mismatched eplets and self-eplets.
Resse M; Paolillo R; Minucci BP; Moccia G; Napoli C
Tissue Antigens; 2015 Nov; 86(5):368-72. PubMed ID: 26373475
[TBL] [Abstract][Full Text] [Related]
12. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.
Duquesnoy RJ
Hum Immunol; 2002 May; 63(5):339-52. PubMed ID: 11975978
[TBL] [Abstract][Full Text] [Related]
13. A structurally based approach to determine HLA compatibility at the humoral immune level.
Duquesnoy RJ
Hum Immunol; 2006 Nov; 67(11):847-62. PubMed ID: 17145365
[TBL] [Abstract][Full Text] [Related]
14. Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation.
Laux G; Mytilineos J; Opelz G
Transplantation; 2004 Mar; 77(6):902-7. PubMed ID: 15077035
[TBL] [Abstract][Full Text] [Related]
15. Highly Immunogenic DQB1 Mismatch Eplets Are Associated With Development of Chronic Active Antibody-Mediated Rejection: A First Report From Japan.
Iwami D; Hotta K; Sasaki H; Hirose T; Higuchi H; Takada Y; Shinohara N
Transplant Proc; 2017; 49(1):84-87. PubMed ID: 28104165
[TBL] [Abstract][Full Text] [Related]
16. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
[TBL] [Abstract][Full Text] [Related]
17. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
[TBL] [Abstract][Full Text] [Related]
18. Eplet Mismatch Load and
Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
[TBL] [Abstract][Full Text] [Related]
19. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
Duquesnoy RJ; Marrari M
Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
[TBL] [Abstract][Full Text] [Related]
20. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens.
Dankers MK; Witvliet MD; Roelen DL; de Lange P; Korfage N; Persijn GG; Duquesnoy R; Doxiadis II; Claas FH
Transplantation; 2004 Apr; 77(8):1236-9. PubMed ID: 15114091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
